Overview

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy and safety of NGX-4010 applied for 60 minutes for the treatment of postherpetic neuralgia (PHN).
Phase:
Phase 3
Details
Lead Sponsor:
NeurogesX
Treatments:
Capsaicin